COMP <GO>
AHCO vs MRK // OPERATING MARGIN
AdaptHealth Corp. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: AHCO 1
— MRK 10
▲ OPERATING MARGIN LEADER: MRK
LAST: $5.81 (-2.02%) • MKT CAP: $808.5M
operating-margins
2.80%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHCO VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHCO | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.80% | 74.80% | -56.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.20% | 20.70% | -18.50 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 15.3x | -9.20 | AHCO | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 2.80% | 34.30% | -31.50 | MRK | /operating-margins <GO> |
| Net Profit Margin | -2.20% | 28.10% | -30.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -0.50% | 1.30% | -1.80 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.79 | 5.19 | -4.40 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 51.7 | -3.60 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $808.5M | $361.02B | -$360.21B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHCO REV | MRK REV | AHCO GROSS % | MRK GROSS % | AHCO FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.24B | $65.01B | 18.8% | 74.8% | $219.4M | $12.36B |
| FY 2024 | $3.26B | $64.17B | 20.9% | 76.3% | $235.8M | $18.10B |
| FY 2023 | $3.20B | $60.12B | — | — | $480.7M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHCO // BETA —
MRK // BETA 0.92